Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

People with localized prostate cancer treated according to guidelines developed by an international panel of doctors are more likely to die of something other than the disease, new research shows. A ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

A new blended genome genetic test being studied in a major clinical trial may help identify men at highest risk of aggressive ...

Many men with low levels could be spared from invasive procedures and frequent testing ...

Urologists at University of California, San Diego School of Medicine and Genesis Healthcare Partners have tested a new model of care for patients with low-risk prostate cancer. The evidence-based ...

A plant-based diet combined with probiotics reduces PSA increase in men and lowers prostate cancer risk by 3x.

Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes. HealthDay News — Men with nonmetastatic prostate cancer receiving ...

New research links PSA and PSA density to long-term prostate cancer risk, supporting risk-adapted screening strategies. Learn more about the 20-year findings.

At 25 years, the prostate cancer-specific survival rate was 94% among men with screen-detected prostate cancer who chose primary active surveillance – but prostate cancer progression rates are high.

New research shows that vegetables and probiotics may help to stabilise or retard tumour growth in the prostate.

Of all the health conditions facing men as they get older, there is no doubt that prostate cancer is the most widely ...